Comparing two forms of a study medicine in healthy adults
Part of Brain & nervous system clinical trials.
This early-stage study tests whether two different formulations (forms) of a new medicine reach similar levels in your bloodstream. You'll need to be healthy with no significant medical conditions, and the study helps Pfizer understand how well each version works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old and in good overall health (no major heart, kidney, lung, liver, or psychiatric conditions)
- Have a body mass index (BMI) between 16–32 and weigh more than 45 kg (about 99 lbs)
- Not be taking any prescription medications, over-the-counter drugs, or herbal supplements for at least 14 days before the study starts
- Not have participated in another drug or vaccine study within the past 30 days
- Have a negative urine drug test (screening may be repeated once if needed)
- Be able and willing to follow all study rules, including dietary and lifestyle restrictions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
This trial tests whether a computer algorithm can help pick the best migraine prevention medicine for you. You'll try one of several common preventives and track your headaches.
This trial tests a new medicine, MEDI0618, against a placebo for people with episodic migraine. The goal is to see if MEDI0618 is safe and effective at reducing migraine days.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial tests which form of a study drug for COVID-19 is better absorbed by the body. It involves healthy adults and requires two separate visits to take each version, with blood draws to measure drug levels.
This study tests whether two different formulations of an experimental medication (AJU-C715) work the same way in your body. Researchers will give you one version and then later the other version to compare how much of the drug enters your bloodstream and how long it stays there.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.